Zenotech Laboratories Limited (532039) - Pharmaceuticals & Hea...Zenotech Laboratories Limited (Zenotech), develops and manufactures generic biopharmaceuticals. It classifies its products into two categories, namely, generic biopharmaceuticals and new biological. The company's Generic biopharmaceuticals is ... TransWorldNews, 1 day ago |
Biosimilar Drug Revenues Will Reach $2,445m Worldwide in 2013, Predicts New visiongain ReportA new report by visiongain predicts the world market for biosimilar drugs will be worth $2,445m in 2013, growing by more than 20% from 2012. In 2013 it will account for around 2% of the overall biologics (biological drugs) market. That study ... ADVFN India, 2 weeks ago
|
Andhra Pradesh: From bulk drugs to affordable medicines, vaccines"In Hyderabad, entrepreneurs are driven by a herd mentality. If there is one successful venture, a dozen will follow. The high number of bulk drug manufacturers in a way is just manifestation of such a trend". Habil Khorakiwala, Chairman of ... Hindu Business Line, 3 weeks ago
|
Competitor Analysis: G-CSF and GM-CSFhe present Competitive Intelligence Report about G-CSF and GM-CSF product portfolios and R&D pipelines provides a competitor evaluation in the field of G-CSF & GM-CSF branded products in regulated markets and products in non-regulated markets, ... Research and Markets, 4 weeks ago
Competitor Analysis: Antibody Therapy of Inflammatory and Autoimmune Diseases
PipelineReview, 1 month ago
|
Age Related Macular Degeneration - Pipeline Review, H1 2013Age Related Macular Degeneration Pipeline Review, H1 2013 Summary Global Markets Direct's, ' ', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Age Related Macular ... Research and Markets, 1 month ago
Breast Cancer - Pipeline Review, H1 2013
Research and Markets, 1 month ago
Rheumatoid Arthritis - Pipeline Review, H1 2013
Research and Markets, 1 month ago
Multiple Sclerosis - Pipeline Review, H1 2013
Research and Markets, 1 month ago
|
Next-Generation Antibody Therapeutics Market 2013-2023/PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: ... TickerTech.com, 1 month ago
|
Competitor Analysis: VEGF Antibodies - Bevacizumab and Ranibizumab Biosimilars and BiosuperiorsResearch and Markets (http://www.researchandmarkets.com/research/whsrrt/competitor) has announced the addition of the "" report to their offering. The present Competitive Intelligence Report about VEGF Antibodies - Bevacizumab and Ranibizumab ... Individual.com, 1 month ago
Research and Markets: Competitor Analysis: VEGF Antibodies - Bevacizumab and Ranibizumab Biosimilars and Biosuperiors
TMC Net, 1 month ago
More from: , Reuters...and 2 other sources
|